Ossianix to Present Preclinical Data Demonstrating Best-in-Class Blood Brain Barrier Delivery in Non-Human Primates by Single Domain VNAR Antibodies
– Over 30-Fold Increase in Hippocampus Observed –
– Results Promising for Delivery of Biological Therapeutics for Neurologic Diseases –
– Results to be Presented at Protein & Antibody Engineering Summit Europe –